Bolt Biotherapeutics (BOLT) EBITDA Margin (QoQ) (2020 - 2026)
Bolt Biotherapeutics (BOLT) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Bolt Biotherapeutics | 5.92 Mn | 5.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.82 Mn |
| Mar 31, 2026 | -2.90 Mn |
| Dec 31, 2025 | 7,174.00 |
| Sep 30, 2025 | 15,539.00 |
| Jun 30, 2025 | 48,088.00 |
| Sep 30, 2024 | 33,121.00 |
| Jun 30, 2024 | -144,823.00 |
| Mar 31, 2024 | 62,211.00 |
| Dec 31, 2023 | -22,693.00 |
| Sep 30, 2023 | 66,469.00 |
| Jun 30, 2023 | -37,546.00 |
| Mar 31, 2023 | 48,265.00 |
| Dec 31, 2022 | -43,309.00 |
| Sep 30, 2022 | 59,730.00 |
| Jun 30, 2022 | 128,143.00 |
| Mar 31, 2022 | 239,295.00 |
| Dec 31, 2021 | -220,127.00 |
| Jun 30, 2020 | -1.12 Mn |